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Summary 
The RAG1 and RAG2 gene products are Indispensable 
for activating somatic rearrangement of antlgen recep 
tor gene segments. The two proteins form a stable 
complex in primary thymocytes as well as when ex- 
pressed In adherent cells. In both cell types, most cells 
localize RAG proteins at the periphery of the nucleus. 
However, when over-expressed in flbroblast cells, 
RAG1 is found largely in the nucleolus. Nucleolar local- 
ization of RAG1 is mediated by several domains con- 
taining stretches of basic amino acids, Indicating that 
RAG1 has affinity for RNA or ssDNA. The RAG1 lnter- 
acting proteins SRPl and Rchl directly bind to the 
nuclear locallxatlon signals of RAGl, which mediate 
the nuclear and nucleolar translocation of the protein. 
RAG1 appears to have a binary structure, each half 
containing multlple regions that can act as NLSs, blnd- 
lng sites for the SRPlIRchl family, and RNA binding 
domains. 
In the developing immune system, diversity of the antigen 
receptors, immunoglobulin, and T cell receptor (TCR) is 
generated by somatic rearrangement of gene segments 
in a site-specific process termed variable(diverse)joining 
(V[D]J) recombination (Tonegawa, 1983; Alt et al., 1987). 
This process is directed by highly conserved DNA recom- 
bination signal sequences (RSS) and executed by both 
ubiquitous and lymphoid-specific proteins (for review see 
Lewis and Gellert, 1989; Lieber, 1991; Schatz et al., 1992). 
Current models of V(D)J recombination are based mainly 
on the identification of V(D)J recombination intermediates 
(Roth et al., 1992; van Gent et al., 1995). Evidence for 
the involvement of ubiquitous activities stems from the 
analysis of the mutant nonlymphoid cell lines deficient in 
both V(D)J recombination and DNA repair (Kemp et al., 
1984; Whitmore et al., 1989; Fulop and Philips, 1990; Hen- 
drickson et al., 1991; Pergola et al., 1993; Taccioli et al., 
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1993). The ubiquitous DNA repair proteins, Ku70 and 80, 
along with the DNA-dependent protein kinase defective 
in mouse scidcells are three proteins essential for resolu- 
tion of the hairpin loop formed during the V(D)J recombina- 
tion process (Bosma and Carroll, 1991; Gottlieb and Jack- 
son, 1994; Taccioli et al., 1994; Rathmell and Chu, 1994; 
Kirchgessner et al., 1995; Lees-Miller et al., 1995; Blunt 
et al., 1995). 
The three lymphoid-specific components identified so 
far are the terminal deoxynucleotidyl transferase (TdT) en- 
zyme, which contributes to junctional diversity (Landau et 
al., 1987; Gilfillan et al., 1993; Komori et al., 1993) and 
the V(D)J recombination-activating gene products, RAG1 
and RAG2. These two genes reside adjacent to each other 
and were cloned by virtue of their ability to activate V(D)J 
recombination of an artificial recombination substrate in 
fibroblasts (Schatz et al., 1989; Oettinger et al., 1990). 
In mice carrying homozygous deletions of either RAG1 
(RAGl-‘-) or RAG2 (RAG2-I-), lymphocyte development is 
arrested at the point at which V(D)J recombination of the 
TCR or immunoglobulin loci would have normally oc- 
curred. As a result, the mutant mice are immunodeficient 
due to the lack of any functional B or T cells (Mombaerts 
et al., 1992; Shinkai et al., 1992; Spanopoulou et al., 1994). 
The total absence of antigen receptor rearrangements in 
the RAGl+ or RAG2-‘- mice emphasizes the indispens- 
able role of these two proteins in the V(D)J recombination 
process. This notion is reinforced by the recent findings 
that in an in vitro system, the RAG1 protein is essential 
for specific cleavage and the formation of hairpin ends 
(van Gent et al., 1995). 
Deletional analysis has defined the minimal regions of 
RAG1 and RAG2 required for their catalytic function. This 
analysis indicated that amino acids 330-1008 of RAG1 
and l-388 of RAG2 constitute the active core of the two 
proteins that mediate V(D)J recombination in fibroblastic 
cell lines (Silver et al., 1993; Sadofsky et al., 1993, 1994; 
Cuomo and Oettinger, 1994). Two proteins, Rchl and 
SRPl, were found to associate with RAG1 (Cartes et al., 
1994; Cuomo et al., 1994). SRPl interactswith the N termi- 
nus of the protein (amino acids l-288) outside of the 
RAG1 active core. To gain further insight into the precise 
function of RAG1 and RAG2 in V(D)J recombination, we 
analyzed their interaction and intracellular localization. 
Results 
RAG1 and RAG2 Protein Distribution 
To examine the intracellular localization of the RAG pro- 
teins, both monoclonal and polyclonal antisera were 
raised against RAG1 and RAG2. The specificity of the sera 
was validated by comparing proteins in RAG-expressing 
normal cells versus cells derived from either RAGl-‘- or 
RAGP-‘- mice (see data in individual experiments below). 
Western blots were prepared from extracts of either pri- 
mary thymocytes or cell lines expressing high levels of 
recombinant RAG protein and were probed with the spe- 
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cific antisera. Both in thymocytes and overproducers, 
RAG2 was readily detectable (Figure la, lanes 5 to 7). 
By contrast, low levels of RAG1 protein were present in 
primary thymocytes (Figure la, lanes 2,3), in spite of the 
relatively high levels of RAG7 mRNA found in the thymus 
(Schatz et al., 1989; Oettinger et al., 1990). The majority 
of both proteins was not soluble in 0.2M NaCl but was 
solubilized in 0.7M NaCl (Figure la, compare lanes 2 with 
3, and 6 with 7). No RAG proteins could be detected in 
the thymus of RAG-‘- mice (Figure la, lanes 4,8). Subse- 
quently, the distribution and stability of the RAG proteins 
was followed by immunoprecipitation assays in the pres- 
enceof high concentration of NaCl to include the insoluble 
nuclear fraction. Using extracts from cells metabolically 
labeled with [32P]otthophosphate, both RAG1 and RAG2 
were found to be phosphotylated (Figure 1 b, lanes l-4). 
The stability of the two proteins was followed by pulse- 
chase radiolabeling of fibroblasts expressing the RAG pro- 
teins, or of primary thymocytes. In these assays, RAG1 
exhibited a half-life of about 15 min in both cell types (Fig- 
ure 2a, lanes 5-7 and 8-12). In contrast, RAG2 had a 
half-life of about 1 hr (Figure 2a, lanes l-4). The relative 
stability of RAG2 was also indicated by the weak intensity 
of the labeled immunoprecipitated protein from thymo- 
cytes even after 3 hr of labeling (Figure 2a, lane 14). 
Physical Interaction between RAG1 and RAG2 
In extracts from primary thymocytes immunoprecipitated 
with an anti-RAG2 serum (pAbP), RAG2 coprecipitated a 
protein of the same molecular weight as RAG1 (Figure 
2a, lanes 12 and 14) which was absent from RAGI-‘- 
thymic extracts (data not shown). In the same experiment, 
the anti-RAG1 serum (pAb1) precipitated RAG1 but no 
b. 
obvious RAG2 protein could be observed (Figure 2a, lanes 
13 and 15). This is probably due to the slow turnover rate 
of RAG2 protein. 
To examine the specificity of the polyclonal anti-RAG1 
(pAb1) and anti-RAGP(pAb2) antisera used in these exper- 
iments, they were tested with lymphoid cell extracts de- 
rived from RAGi-‘-- or RAG2-‘-deficient mice, respec- 
tively (Shinkai et al., 1992; Spanopoulou et al., 1994; 
Corbella et al., 1994). pAb1 and pAb2 detected RAG1 and 
RAG2, respectively, in extracts from wild-type lymphoid 
cells but not in lines derived from RAG-deficient mice, 
demonstrating their specificity (Figures 2b, 2~). 
To confirm the RAGl-RAG2 interaction, the proteins 
were transiently expressed either separately or simultane- 
ously in 293T cells, and extracts were immunoprecipitated 
using anti-RAG sera, subjected to Western blot analysis 
and analyzed with the same sera. In this experiment, the 
anti-RAG1 serum clearly immunoprecipitated RAG2 and 
vice versa (Figure 2d). 
Interaction of the two RAG proteins could also be dem- 
onstrated with 35S-metabolically labeled extracts, indepen- 
dently of the anti-RAG sera. To accomplish this, RAG2 
was tagged with glutathione S-transferase (GST-RAGP) 
and RAG1 with an influenza peptide (HA-RAGl). The ex- 
pression constructs were transiently transfected into 293T 
cells and the cell lysates were subjected to immunoprecipi- 
tation using antisera against GST or HA. The anti-GST 
serum precipitated RAG2 along with a protein of the same 
molecular weight as RAG1 (Figure 3, lane 5). Conversely, 
the anti-HA serum precipitated RAG1 plus a protein of the 
same molecular weight as RAG2 (Figure 3, lane 6). The 
identity of the two coprecipitated bands was confirmed 
by the observation that they were absent from cells that 
f 
Figure 1. Analysis of RAG Proteins by lmmunoprecipitation and Western Blotting 
(a) RAG1 and RAG2 distribution analyzed by Western blotting. The material soluble in 0.2 M NaCl (lanes 3 and 7) and 0.7 M NaCl (lanes I, 2, 
4, 5, 6, and 6) of cellular extracts from murine thymocytes (lanes 2-4 and 6-6) or 293T cells expressing either recombinant RAG1 or RAG2 (lanes 
1 and 5, respectively), were submitted to Western blot analysis using a mouse MAb against RAG1 (lanes l-4) (MAb-1, Pharmingen) or rabbit 
polyclonal antisera against RAG2 (lanes 5-6) (pAb2). 
(b) Both RAG1 and RAG2 proteins are phosphorylated. YP-labeled lysates from primary thymocytes or 3T3 cells expressing RAGS (Silver et al., 
1993) were analyzed by immunoprecipitation using the rabbit polyclonal antisera pAb-1 (lanes 1 and 2) and pAb-2 (lanes 3 and 4). 
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expressed either RAG1 or RAG2 alone (Figure 3, lanes 1 
and 4). To test whether the observed RAGl-RAG2 protein 
interaction is an artificial effect of the overexpression of 
the two proteins, RAG1 or RAG2 were coexpressed with 
the NF-KB components ~65 or ~50, respectively (Ghosh 
et al., 1990). Despite the high levels of expression of p65 
or ~50 in these cells, no obvious RAGl-p65 or RAG2- 
~50 interaction was observed (Figure 3, lanes 7-10) thus 
confirming thegenuine nature of the RAGl-RAG2 interac- 
tion. Interestingly, the ratio of RAGl-RAG2 in the copre- 
cipitated complex was about l/4 as judged by %-labeled 
extracts once the % content of the two proteins was taken 
into account (Figure 3, lane 6). It should be noted that 
pulse-chase experiments with cells stably expressing ei- 
ther wild-type RAG1 or RAG2, individually or both to- 
gether, showed that the RAG1 -RAG2 interaction does not 
Figure 2. Stability and Interaction of the RAG 
Proteins 
(a) lmmunoprecipitation analysis of %-labeled 
extracts from 3T3 cells expressing either re- 
combinant RAG2 or RAG1 (lanes l-4 and 6-7, 
respectively) (Silver et al., 1993). Cells were 
pulsed for 3 hr and aliquots of equal numbers 
of cells were chased for the indicated times. 
The pulse-chase assay was also performed 
with YYabeled extracts from primary thymo- 
cytes (lanes 6-15) using the indicated antibod- 
ies. Abbreviations signify the following: pAb-2, 
rabbit polyclonal antisera against RAGP; 
pAb-1. rabbit polyclonal against RAGl; lP, 1 
hr pulse; 112,1,X, chase time. Bottom repre- 
sents a scanned image of lanes l-4. 
(b) Specificity of polyclonal rabbit anti-RAG1 
serum, pAb1. lmmunoprecipitate of RAGV-I 
TCRaf3+ (Corbella et al., 1994) (lane 16) and 
wild-type thymocyte extracts (lane 17). 
(c) Specificity of polyclonal rabbit anti-RAG2 
serum. lmmunoprecipitate of extracts from Ab- 
elson virus transformed preB cell lines from 
RAGP-‘- (Shinkai et al., 1992) (lane 16) and 
wild-type mice (lane 19). 
(d)The RAG1 and RAG2 proteins interact when 
coexpressed in 293T cells. Extracts from 293T 
cellsexpressingeither RAG1 (lane20)or RAG2 
(lane 21) or both proteins (lanes 22 and 23) 
were subjected to immunoprecipitation using 
the indicated polyclonal antisera. The immuno- 
precipitated products were subsequently ana- 
lyzed by Western blotting using the same poly- 
clonal antisera (pAb-1 and pAb-2). 
appear to influence the stability of either protein (data not 
shown). 
The RAGl-RAG2 interaction was also studied in the 
yeast two-hybrid system. RAG1 and RAG2 were cloned 
and expressed in the appropriate yeast expressionvectors 
that would allow transactivation of a reporter construct 
upon specific interaction of the two proteins (Zervos et al., 
1993; Cortes et al., 1994). However, coexpression of the 
two proteins in yeast cells failed to reveal any direct inter- 
action between the RAG1 and RAG2 proteins. Similarly, 
the two proteins failed to interact when coexpressed in 
reticulocyte lysates (data not shown). Thus, there may be 
a third protein, as yet unidentified, mediating the RAGl- 
RAG2 interaction or the interacting species may be mole- 
cules that have been posttranslationally modified in mam- 
malian cells. 
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Figure 3. Coimmunoprecipitation of Hybrid 
RAG Proteins 
RAG1 was tagged at the N terminus with an 
influenza epitope (RI-HA) and FLAG2 was 
fused to the glutathione S-Vansferase protein 
(RP-GST). The two proteins were expressed 
either together (lanes 5 and 6) or separately 
(lanes l-4) in 293T cells. After transient Vans- 
fection (45 hr), the cells were subjected to “S 
labeling for 3 hr and the nuclear extracts were 
analyzed by immunopracipitatiin using anti- 
bodies against either the influenza peptide 
(lanes 2. 4, and 6) or the GST protein (lanes 
1, 3, and 5). As a control, RAG proteins were 
also coaxpressed with modified versions of the 
NF-KB proteins, p!+HA and p95-GST (Liou et 
al., 1994). Rl-HA was coexpressed with p95- 
GST (lanes 7 and S), while R2-GST was coex- 
pressed with pW-HA (lanes 9 and 10). 
1234 5 6 7 8 9 10 
Subcellular Localization 
To obtain further insight into the properties of the RAG 
proteins, the specific antisera were used in immunofluo- 
rescence studies. In primary mouse thymocytes, RAG1 
was difficult to detect because of its low level, but there 
was a consistent specific signal at the periphery of most 
nuclei (Figure 4A). in addition, in some cells RAG1 was 
found in nuclear speckles, often coincident with nucleoli 
(Figure 4A). These signals were absent in thymocytesfrom 
RAGl-‘- cells. RAG2 also localized to the periphery of 
the positive nuclei but at much higher levels than RAG1 
(Figure 48). This signal was absent in RAGP-‘- thymo- 
cytes. Although not ail cells give a uniform picture, it ap- 
pears that RAG1 and RAG2 are in the nuclear periphery 
in the majority of thymocytes. 
In fibroblast lines expressing relatively low levels of 
RAG1 and RAG2 from the retroviral vector pGD, both pro- 
teins were found near the periphery of the nucleus (Figure 
4C, similar data for RAGl), in agreement with the distribu- 
tion observed in primary thymocytes. However, a very dif- 
ferent pattern of distribution was observed when the RAG 
proteins were expressed at high levels in the same cells 
(Silver et al., 1993). RAG2 was then evenly distributed 
throughout the nucleus but spared the nucleolus (Figure 
4D). However, RAG1 showed a very different distribution, 
with the majority of the protein being localized as speckles 
within the nucleus (Figure 4E). Speckled distribution was 
also evident in fibroblasts coexpressing both RAG1 and 
RAG2, but in this condition much of the RAG1 was more 
evenly distributed in the nucleus, presumably by virtue of 
its interaction with RAG2 (Figure 4F). 
The speckles of RAG1 coincided with the position of 
nucleoli evident by phase contrast microscopy. The nucie- 
alar localization of RAG1 was confirmed by costaining with 
rhodamine-labeled anti-RAG1 and fluorescein-labeled 
anti-Nopp 140, a nucleolar chaperone protein (Meier and 
Blobel, 1992). RAG1 colocalized with Nopp 140 in the nu- 
cleolus (Figure 4G). However, as previously reported 
(Meier and Blobel, 1992), Noppl40 localized only in the 
fibrillar compartment of the nucleoli, while RAG1 was also 
present in the granular compartment. 
To examine whether overexpressed RAG1 was in 
nucleoli because of an affinity for RNA, the nucieolar RNA 
was selectively depleted by treatment of the ceils with low 
levels of actinomycin D (0.2 @ml), which specifically in- 
hibits RNA poiymerase I transcription (Perry, 1962; Goid- 
berg and Friedman, 1971). The majority of the RAG1 pro- 
tein 2 hr after treatment was no longer in the nucleoli but 
rather was distributed throughout in the nucleus in tiny 
speckles (Figure 4H), perhaps at places with a high con- 
centration of RNA (Li and Bingham, 1991; Kalland et al., 
1994) or in origins of replication (Adachi and Laemmli, 
1994). By contrast, the localization of Nopp 140 remained 
unaffected by the actinomycin D treatment (data not 
shown). Thus, RAG1 appears to have a high affinity for 
RNA and when overexpressed without RAG2 it binds to 
sites of high RNA concentration. 
Role of RAG1 Basic Motifs: Binding Sites 
for the SRPlIRchl Family 
Several amino acid motifs have been described that medi- 
ate the binding of proteins to RNA (Bandziulis et al., 1989; 
Burd and Dreyfuss, 1994; LaCasse and Lefebvre, 1995). 
The RAG1 protein (Schatz et al., 1989) does not appear 
to contain within its primary sequence any of the motifs 
described for the RNA-associating nucieoproteins (Band- 
ziulis et al., 1989), but it does contain multiple motifs of 
consecutive basic amino acids that could potentially con- 
fer RNA affinity on the protein, as demonstrated for the 
RNA binding proteins Tat, Rev, and Rex (Siomi et al., 
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1988; Ruben et al., 1989; Cochrane et al., 1990; Calnan 
et al., 1991; Kjems et al., 1992). To define the domains 
of RAG1 that mediate nuclear and nucleolar localization, 
we generated several internal deletions (A) or amino acid 
alterations (M) or both within the basic domains of the 
RAG1 protein. The mutant RAG1 proteins were tested for 
their nucleolar localization when overexpressed in 293T 
cells and in functional assays for their ability to activate 
V(D)J recombination (Table 1). In addition, recent studies 
have indicated that the RAG1 -interacting proteins SRPl 
(Cortes et al., 1994) and Rchl (Cuomo et al., 1994) medi- 
ate nuclear translocation of proteins containing a nuclear 
localization signal (NLS) (Gorlich et al., 1994; Weis et al., 
1995). Our previous studies had shown that SRPl inter- 
acts with an N-terminal segment of RAG1 (amino acids 
l-288; Cortes et al., 1994) whereas a fragment of Rchl 
(amino acids 432-529) interacts with the C-terminal region 
of the protein (330-1040; P. C. and D. B., unpublished 
data). Therefore, we used the yeast two-hybrid system and 
immunoprecipitation assays to test in parallel the ability 
of the different RAG1 mutants to interact with either SRPl 
or Rchl. 
Deletion of aminoacids 13-330 in RAG1 , which includes 
the ring finger motif, did not impair nuclear localization 
but decreased the amount of nucleolar RAG1 , suggesting 
that sequences towards the N terminus of the protein may 
partly contribute to nucleolar binding (Silver et al., 1993). 
The A13330 mutant protein retained 50% of wild-type 
functional activity(Table 1; Silver et al., 1993). This mutant 
failed to interact with SRPl but it retained interaction with 
Rchl (Table 1; Table 2). The deleted amino acid 13-330 
region contains three basic regions: amino acids 141-l 48 
(region Bl), amino acids 222-225 (811) and amino acids 
243-249 (8111). Mutation within the BI region (142,143 KK 
to II; Table 1) partly relocalized RAG1 to the periphery of 
the nucleus but had no effect on its activity (see Table 1; 
Silver et al., 1993). Mutation of Bll (KRKR to IVKL; see 
Table 1) did not affect nucleolar localization or activity (see 
Table 1). Mutationofaminoacids233-238(KKLKto LGLA) 
left the protein nucleolar and fully active (see Table 1). 
A deletion that encompasses the third basic domain Bill 
(amino acids 243-254, see Table 1) produced a fully func- 
tional protein that was partly in the nucleolus and partly 
in the nucleus (see Table 1). The latter suggests that RAG1 
is partly driven in the nucleolus by regions BI and Bill and 
that additional sequences must contribute to this localiza- 
tion because of the behavior of the 13-330 deletion. Since 
additional basic motifs are present at the C terminus of 
RAG1 (amino acids 828-840 [motif BIV] and 989-973 [mo- 
tif BV]), individual point mutations or internal deletion of 
these motifs were generated. 
Deletion of amino acids 814-838 removing half of the 
BIV region (see Table 1) had an interesting effect. In some 
cells, the mutant protein was exclusively cytoplasmic, 
while in others it was present in both nucleus and cyto- 
plasm but was not nucleolar. Mutation of the basic amino 
acids in this region (amino acids 823-828, KEERKR to 
IEELMI) resulted in only part of the protein residing in the 
nucleolus, while the rest was evenly spread through the 
nucleus. Both mutants were compromised in the V(D)J 
recombination assay (see Table 1). Mutation within the 
adjacent basic motif (amino acids 835844) yielded a mu- 
tant RAG1 protein distributed between the nucleus, the 
nucleolus, and the cytoplasm but still 70% active (see 
Table 1). Finally, mutations within the BV region (amino 
acids 989-973, RRFRK to IKFLI) produced a totally cyto- 
plasmic and inactive protein. Mutation of adjacent amino 
acids (amino acids 984987, GNKL to AQGI) has no effect 
on localization or activity of RAG1 . 
The ability of the identified RAG1 basic motifs to drive 
localization of a heterologous protein to the nucleolus was 
tested by producing fusion proteins between the individual 
motifs and GST (Table 2). When a GST-RAG1 fusion pro- 
tein containing the middle part of RAG1 (amino acids 278- 
477) was expressed in 293T cells as a negative control, 
the protein was cytoplasmic (data not shown). However, 
the GST fusion of amino acids 120-277 yielded a protein 
that localized to the nucleolus in most cells and was more 
diffusely nuclear in others (Figure 41). 
The C-terminal 330-1040 RAG1 sequence could also 
drive nuclear and nucleolar localization of GST. Fusion of 
amino acids 758-877 to GST gave a cytoplasmic protein 
(Table 2). Expression of amino acids 918-997, however, 
drove the GST fusion protein into the nucleus (Table 2). 
To map more precisely the relevant sequences, we in- 
troduced mutations of the individual basic motifs into the 
RAG1 derived portions of the fusion proteins (Table 2) and 
studied their subcellular distribution by immunofluores- 
cence. In parallel, we tested the ability of the wild-type 
and mutant fusion proteins to interact with SRPl (Cartes 
et al., 1994) and Rchl (Cuomo et al., 1994) (Table 2) using 
immunoprecipitation assays and the yeast two-hybrid sys- 
tem. This analysis revealed that all three basic motifs 
within the N terminus (BI, Bll, and 8111) (Figure 5) of RAG1 
were binding sites for SRPl , because mutations in any of 
these domains drastically reduced the RAGl-SRPl inter- 
action as judged by immunoprecipitation (Table 2). This 
reduction also affected the nucleolar localization of RAG1 
(Table 2). SRPl did not interact with the C terminus of 
RAG1 despite the presence of similar basic motifs. Simi- 
larly, Rch-1 only interacted with the C terminus of the pro- 
tein with motifs BIV and BV (Table 2; Figure 5). Motif BIV 
was not sufficient to drive nuclear localization, but BV pro- 
vided a strong signal for nuclear transportation (Table 2). 
Discussion 
The stability, interaction, and localization of RAG1 and 
RAG2 were probed using specific antisera. In the nucleus 
of thymocytes, the two proteins are complexed together 
and concentrated in the periphery. When overexpressed 
individually, however, RAG2 is more evenly distributed 
and RAG1 shows a predominant nucleolar localization. 
Even though there is no correlation of activity with the 
nucleolar concentration of RAG1 , we examined the basis 
of the nucleolar binding for the insight it might give to 
RAG1 function. The localization isdue to not one but multi- 
ple signals that serve both to catalyze transport of the 
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Figure 4. lmmunofluorescence Analysis of Endogenous and Exogenously Expressed RAG1 and RAG2 
In transfected 3T3 cells, only RAG1 or only HAG2 was expressed unless otherwise stated. (A) Endogenous RAG1 protein in primary thymocytes 
detected by the MAb-1. (6) Endogenous RAG2 protein in primary thymocytes detected by pAb-2. (C) HAG2 recombinant protein expressed at 
moderate levels in NIH 3T3 cells (pAb-2). (0) High level expression of recombinant HAG2 in NIH 3T3 cells (PAS-2). (E) High level recombinant 
RAG1 expressed in NIH 3T3 cells (MAb-1). (F) Detection of RAG1 in cells expressing HAG1 plus HAG2 (M&l). (G) Costaining of RAG1 (rhodami- 
nated, anti-mouse IgM) (MAb-1) and Noppl40 (fluorescein-conjugated donkey anti-rabbit) (pAb-Noppl40) in NIH 3T3 cells overexpressing HAG1 
(H) Detection of RAG1 protein after treatment of RAG1 overexpressing NIH 3T3 cells with 0.2 rig/ml of actinomycin D (MAbl) for 2 hr. (I) Expression 
of the RAG1:120-277/GST fusion peptide in 293T cells (pAb-GST). 
protein into the nucleus and to bind to RNA concentrated 
in the nucleoli. These signals serve as binding sites for 
two proteins known to interact with RAG1 and also known 
to be involved in transport of proteins to the nucleus. 
is inversely proportional to their steady-state mRNA levels 
(Oettinger et al., 1990). This suggests that the RAG pro- 
teins are under translational or posttranslational control. 
indeed, both in primary thymocytes and fibroblast lines, 
RAG1 is a very labile protein (independently of the pres- 
Stability of the RAG Proteins ence or absence of RAG2), in contrast with RAGP, which 
RAG1 and RAG2 partition in the soluble as well as the appears to be more stable. Because both proteins are 
insoluble part of the nucleus and their relative expression needed for recombinational activity, RAG1 instability is 
Localization and Properties of RAG1 and RAG2 Proteins 
721 
Figure 4 continued. 
sufficient to ensure that once the synthesis of the proteins ous observations where RAG2 was found to be particularly 
is terminated, their activity will not linger. Given the low unstable (Lin and Desiderio, 1992, 1994). We find that 
efficiency of the V(D)J recombination process that ensures both in primary thymocytes and overexpressing fibro- 
clonality of lymphoid cells, perhaps the labile nature of blasts RAG2 appears to be rather stable; it is RAG1 that 
RAG1 reflects a rate-limiting step in the recombination exhibits instability. One explanation for this discrepancy 
reaction. is that we did not examine rapidly cycling cells because 
Our estimations of the stability of RAG2 differ from previ- the previous work suggested a particular instability in S 
Table 1. Effect of Mutations on the Localization and Activity of RAG1 
Mutant protein Subcellular localization Activity 
Al 3-330’ NucleadNucleolar 4&W% 
M 142, 143 KK to II. Nucleolar w-r 
A 141-146 @I) Nucleolar WT 
M 222-225 KRKR to IVKL (Bll) Nucleolar w-r 
A 243-254 (8111) Nuclear/Less Nucleolar wr 
M 233-236 KKLK to LGLA Nucleolar wr 
A 614-636 (BIV) Cytoplasm, Nucleus/Cytoplasm 10% 
M 623-626 KEERKR to IEELMI (112BlV) Nuclear/Low Nucleolar 0 
M 635-644 KHLRKRMNLK to IHLLILMNLI (1/2BIV) Cytoplasm, Nucleus/Cytoplasm/Low Nucleolar 70% 
M 969-973 RRFRK to ILFLI (BV) Cytoplasmic 0 
M 964-967 GNKL to AQGI Nucleolar wr 
Internal deletions (A) and multiple point mutations (M) were analyzed in the context of the full-length RAG1 protein. The basic motifs that were 
mutagenized are indicated in parenthesis (see Figure 5). Localization was determined in 3T3 (first two mutants) and 2Q3T cells (rest of the mutants) 
expressing only the wild-type or mutant RAG1 forms by immunofluorescence using the MAb-1 antibody. Activity was determined both in 3T3 and 
293T cells, by coexpression of wild-type RAG2 with the different RAG1 forms. 
8 See Silver et al., 1993. 
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Table 2. Properties of RAGllGST Chimeric Proteins 
Interaction with 
RAGlamino acids/GST Mutation Localization SRPI Rchl 
N terminus 
amino acids 13-330 Nucleolar +-I-++ - 
amino acids 120-277 - Nucleolar ++++ 
amino acids 120-277 M 142/143 (El) Nuclear Periphery + 
amino acids 120-277 A 141-148 (Bl) Nuclear Periphery + 
amino acids 120-277 M 222-225 (611) Nuclear/Weak Nucleolar + 
amino acids 120-277 M 234-237 Nucleolar ++++ 
amino acids 120-277 A243-254 (6111) Nuclear Speckles/Weak Nucleolar + 
amino acids 120-277 M 246-250 (8111) Nuclear Speckles/Weak Nucleolar + 
Control 
amino acids 278-477 - Cytoplasmic 
C terminus 
amino acids 330-1040 Nuclear/Nucleolar +++ 
amino acids 758-877 Cytoplasmic +++ 
amino acids 758-877 M 823-828 (BIV) Cytoplasmic 
amino acids 918-997 Nuclear/Low Cytoplasmic +++ 
amino acids 918-997 M 969-973 (BV) Cytoplasmic 
amino acids 918-997 M 984-967 Nuclear/Low Cytoplasmic +++ 
The analyzed proteins were fusions of the indicated amino acids of RAG1 with GST. The indicated mutations were put into these fusion proteins 
(see Table 1 for the precise changes in the M mutants, which all involved replacing basic regions with acidic or neutral ones). The SRPI interactions 
were determined both in the yeast two-hybrid system and by coexpression of GST fusion polypeptides and HA-SRPI into293T cells and subsequent 
immunoprecipitation using antibodies against GST and the anti-HA (influenza) antibody to detect the coprecipitated SRPI protein. The Rch-1 
interactions were only determined in yeast since we were unable to coprecipitate Rch-I and Rag-l from extracts from 293T cells coexpressing 
the two proteins. Localization was determined by immunofluorescence in 293T cells using antibodies against the GST moiety. The basic motifs 
that were mutagenized are indicated in parenthesis (see Figure 5). 
phase. Furthermore, we made an effort to include both the 
soluble and insoluble fractions. Perhaps the most soluble 
form of RAG2 protein shows a different behavior. 4~~ 
RAG1 -RAG2 Interaction 
RAG1 and RAG2 could be coprecipitated from extracts 
derived from primary thymocytes as well as overexpress- 
ing fibroblasts, indicating that they are maintained to- 
gether in a physical complex and might act in coordination 
during the recombination reaction. Interestingly, in fibro- 
blasts coexpressing RAG1 and RAG2 we were unable to 
detect any RAG2 in the nucleolar compartment, sug- 
Rag-1 N 
I II 
Br B:, Em 
=ZZZEc 
SRP1+ 
Bn Bv 
== 
R&l+ 
Figure 5. Motifsof SasicAminoAcids(BI to SV, Shaded in Red) within 
the RAG1 Sequence that Direct Nuclear and Nucleolar Localization 
Bill constitutes the dominant nucleolar signal, while BV is the dominant 
nuclear localization signal, in the context of the full-length protein. 
Motifs BI, 811, and BIV are also involved in nucleolar organization 
auxiliary to the Bill function. Amino acids 141-146 (Bl), 221-224 (Ml), 
and 243-249 (Bill) participate in the SRPI interaction, whereas amino 
acids 826-828/838-840 (BIV), and 969-973 (BV) interact with Rchl. 
The ring finger domain is indicated (Schatx et al., 1989; Freemont et 
al., 1991; Silver, 1992). The light grey area represents the minimal part 
of RAG1 that is required for V(D)J recombination of extrachromosomal 
substrates expressed in fibroblast cells (Silver et al., 1993; Sadofsky 
et al., 1993). 
gesting that the form of RAG1 localizing in the nucleolus 
fails to interact with RAGP. In contrast, coexpression of 
RAG2 relocalizes part of RAG1 into the nucleus, underlin- 
ing their propensity to interact. The RAGl-RAG2 interac- 
tion, although readily detectable in a number of ways in 
mammalian cells, could not be reproduced in the yeast 
two-hybrid system or in reticulocyte lysates (data not 
shown), suggesting that the interaction is generated in a 
complex with one or additional protein(s), or requires a 
specific posttranslational modification. The unequal ratio 
of the interacting proteins (RAGl-RAG2 is -l/4) sug- 
gests that another protein might determine the stoichiome- 
try. This interaction is of particular significance in under- 
standing the precise functions of RAG1 and RAG2 in the 
V(D)J recombination reaction in view of the recent findings 
that RAG1 is directly involved in the recombination pro- 
cess. In an in vitro reaction, RAG1 participates at the very 
first stepof V(D)J recombination, the introduction of adou- 
ble-stranded break (van Gent et al., 1995). Given that 
RAGl-RAG2 are in the same complex, it is expected that 
RAG2 would also have a direct role in the catalysis of 
V(D)J recombination. 
Nuclear Localization of RAG1 and RAG2 
In thymocytes, both proteins localize in the periphery of 
the nucleus, while RAG1 is also seen as speckles in a 
percentage of cells, presumably those where its concen- 
tration is particularly high. The peripheral localization of 
RAGS can be reproduced when the proteins are individu- 
ally expressed in 3T3 cells at low levels, suggesting that 
the cell has a limited number of sites for nuclear RAG1 
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binding after which the excess protein goes to the nucleo- 
lus. It could be that a nonlymphoid protein serves as an 
anchorto these sites for both RAG1 and RAGP. Taking into 
account the propensity of the two proteins to precipitate, it 
is tempting to speculate that V(D)J recombination occurs 
in certain compartments of the nuclear periphery where 
RAGS are constrained and attached to the nuclear enve- 
lope, matrix, or both. Such a mechanism might help to 
overcome the topological constraints imposed by the long 
distances at which the recombining RSSs are located on 
the DNA. 
The subcellular localization of RAG proteins in overex- 
pressing fibroblasts showed a number of interesting fea- 
tures. RAG2 localizes throughout the nucleus but spares 
the nucleolus. Although clearly nuclear, RAG2 does not 
contain any sequence of basic amino acids homologous to 
the already described NLSs (Dingwall and Laskey, 1991; 
Friedberg, 1992; Burd and Dreyfuss, 1994; LaCasse and 
Lefebvre, 1995). Thus, RAG2 must be driven into the nu- 
cleus by an inapparent type of NLS. Alternative NLSs have 
been described for other proteins (LaCasse and Lefebvre, 
1995). The nuclear distribution of RAG1 is partly due to 
the dominant NLS present at the C terminus of the protein 
(region BV) (see Table 1; in the context of the full-length 
protein only the BV mutations render the protein totally 
cytoplasmic). Nuclear localization of RAG1 is also medi- 
ated by the BI, Bll, and Bill basic motifs at the N terminus 
of the protein (Figure 5; see Table 1; deletion of the N 
terminus leaves 50% of the protein nuclear) and to a lesser 
extent by the BIV basic motif (Tables 1 and 2; Figure 5). 
Our studies confirmed that the N-terminal sequences con- 
stitute binding sites for SRPl (Cortes et al., 1994) while 
C-terminal sequences have affinity for Rchl (Cuomo et 
al., 1994). However, mutation of individual basic segments 
revealed that SRPl and Rchl each interact with several 
basic motifs of the RAG1 sequence. Perhaps this multifin- 
ger anchoring of NLS receptors onto RAG1 is mediated by 
the multiple repeats present within the SRPlIRchl family 
(Peifer et al., 1994; Adam, 1995). 
Nucleolar Localization of RAG1 and Interaction 
with the SRPlIRchl Family 
High expression of RAG1 drives most of the protein to both 
the granular and fibrillar compartments of the nucleolus. 
Nucleolar localization of overexpressed proteins can oc- 
cur for several reasons: first, affinity for RNA as in the 
RNA binding proteins Tat, Rev, and Rex, all of which show 
nucleolar distribution because of their ability to bind RNA 
(Siomi et al., 1988; Ruben et al., 1989; Cochrane et al., 
1990; Kalland et al., 1994); second, aff inky for topoisomer- 
ase sites that are present in multiple copies in the ribo- 
somal RNA(rRNA)genes(Bonvenetal., 1985);third, inter- 
action with other nucleolar proteins (Fankhauser et al., 
1991); fourth, serving a role as a nucleolar chaperone pro- 
tein (Meier and Blobel, 1992); fifth, affinity for single- 
stranded DNA (ssDNA) as described for the yeast protein 
SSBl (Jong et al., 1987). Taking into account the observa- 
tions that, first, mutations within the basic motifs of RAG1 
partly abolish nucleolar localization; second, low actino- 
mycin D treatment moves part of the protein out of the 
nucleolus; and third, peptides encompassing the N termi- 
nus motif can cause another protein, GST, to localize in 
the nucleolus (as was observed in the case of Tat, Rev, 
ai Rex; Siomi et al., 1988; Ruben et al., 1989; Cochrane 
et al., 1990) the data suggest that RAGl, like Tat and 
Rev, localizes in the nucleolus by virtue of its affinity for 
structured RNA (Calnan et al., 1991; Kjems et al., 1992) 
or ssDNA (Jong et al., 1987). It should be noted that, in 
preliminary electrophoretic mobility shift assays for RNA 
binding, we were unable to observe any binding of RAG1 
to in vitro transcribed RNAs such as sterile transcripts from 
the immunoglobulin-k (Igk) locus or a 400 nt transcript 
containing the RSSs (data not shown). Thus, it appears 
that the nucleolar binding of RAG1 is not due to a general 
nonspecific affinity of the protein for RNA. 
Two of the RAG1 basic domains, BI and 8111, mediate 
both nuclear and nucleolar localization of RAGl. These 
motifs also interact with SRPl and mutations within either 
the BI, Bll, or Bill motifs reduce the SRPl-RAG1 interac- 
tion and abolish nucleolar localization, suggesting that the 
SRPl familyof proteinscould beimplicated both in nuclear 
and nucleolar translocation. In fact, it has been shown that 
NLSs may also display RNA binding properties (for review 
see LaCasse and Lefebvre, 1995). These data, along with 
the Tat/Rev paradigm, suggest a separation of the nucleo- 
lar targeting of RAG1 into two phases. First, active nucleo- 
lar transportation mediated by SRP-1IRchl and second, 
retention in the nucleolus by virtue of its affinity for RNA/ 
ssDNA. 
The functional significance of the RAG1 RNA affinity 
remains to be determined. The N-terminal third of the pro- 
tein, which has one of the clusters of basic regions, is 
dispensable for the V(D)J recombination activity of RAG1 
in fibroblast cells (Silver et al., 1993; Sadofskyet al., 1993). 
However, it is indispensable for the V(D)J activity of RAG1 
in Abelson virus-transformed preB cell lines (C. Roman 
and D. B., personal communication), suggesting that in 
lymphoid cells both of the clusters participate in recombi- 
nation. Although it is conceivable that RNA binding plays 
some role in recombination, no such role has been directly 
implicated and it seems more profitable to consider the 
possibility that there are multiple single-stranded DNA 
binding regions. Perhaps RAG1 uses its basic motifs for 
specific binding to nonconventional DNA structures (e.g., 
a bubble of “melted” DNA) similar to the fashion by which 
the C terminus of p53 (which contains motifs of basic 
amino acids) binds to mismatched DNA (Lee et al., 1995; 
Jayaraman and Prives, 1995). Interestingly, two other pro- 
teins, T180 (Shirakata et al., 1993) and the DNA repair 
protein Ku80 (Taccioli et al., 1994), both of which have 
been implicated in the V(D)J recombination process, also 
localize to the nucleolus when overproduced (Hsu et al., 
1993; Higashiuraetal., 1992). In fact, thesubcellulardistri- 
bution of the Ku protein remarkably resembles that of the 
RAG1 protein, suggesting that like Ku, RAG1 may bind 
to ends or short single-stranded regions in DNA. It is likely 
that in the process of recombining DNA RAG1 must have 
affinity for cleaved DNA ends or short single-stranded seg- 
ments. 
Finally, it should be noted that the presence of NLS, 
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nucleolar attachment motifs and SRPi/Rchl binding sites 
in both the N and C terminus of the protein suggest that 
RAG1 has a binary structure (Figure 5). In this regard, it 
may be significant that a recombination protein has to bind 
to two DNA elements so as to appose them for recombi- 
nation. 
Experimental Procedures 
Recomblnent DNA Clones 
For bacterial expression, the RAG fragments containing the coding 
nucleotides, 1890-312001 RAGf and 380-1581 of RAG2, were gener- 
ated by polymerase chain reaction (PCR) and cloned as 5’ BamHI- 
Xhol 3’ fragments into the pT7 vector (Andino et al., 1993). 
For expression in mammalian cells, wild-type RAG7 and RAG2 plas- 
mids were expressed in the CDM-8 vector as previously described 
(Oettinger et al., 1990). Also, the wild-type full-length RAG1 and RAG2 
proteins and all of their truncated forms (Tables 1 and 2) were ex- 
pressed asglutathione transferasefusion proteins in the peBG expres- 
sion vector @‘BarnHI-Not1 Yfragments). peBG (agift of Dr. B. Mayer) 
is a modified version of peFOS (Mizushima and Nagata, 1990) that 
allows production of fusion proteins to the glutathione transferase 
protein. 
For cloning into the yeast transactivation vector peg202 (Zervos et 
al., 1993), parts of RAG1 were amplified by PCR, sequenced, and 
cloned as SBamHI-Notl S’fragments. The full-length SRPl and region 
432-529 of Rch-1 were cloned into the yeast library vector pJG4-5 
(Zervos et al., 1993) as 5’ EcoRI-Xhol 3’ fragments. 
Antibodies 
Purified polyclonal antisera against the glutathione transferase protein 
were a gift from Dr. B. Mayer. Polyclonal antisera against the nucleolar 
chaperone Noppl40 protein were provided by Dr. T. Meier. Anti- 
influenza haemmaglutinin (HA) monoclonal antibody (MAb) (12CA-5) 
was purchased from Berkeley Antibody. 
Generatlon of Antl-RAG Antlbodies 
Fragments of the RAG1 and RAG2 genes encoding amino acids 830- 
1040for RAG1 andaminoacids 120-527for RAGPwerecloned into the 
bacterial expression vector pT7 and expressed in the T7 polymerase- 
expressing bacterial cells BL21 (DE3) after IPTG induction (Andino et 
al., 1993). Bacterial lysates were separated on polyacrylamide gels, 
stained with Coomasie Blue, fixed with methanol/acetone, and the 
RAG1 and RAG2 polypeptides were excised, dried, and injected sub- 
cutaneously into rabbits as described (Antibodies, CSH). The same 
polypeptides were separated by electrophoresis, electroeluted from 
the gel, and injected into mice to generate MAbs (Antibodies, CSH). 
A MAb against RAG1 (PharMingen, catalog number G109-258) was 
successfully used in immunofluorescence, immunoprecipitation, and 
Western blot analyses. 
Protein Preparation 
cDNAs encoding full-length RAG1 or truncated GST fusion proteins 
were transfected into 293T cells by calcium phosphate precipitation, 
expressed transiently for 48 hr, and purified by a one-step purification 
procedure using glutathione-agarose beads (Molecular Probes) (see 
below). 
Western Blot Analysis 
Cellular extracts were lysed in 10 mM Tris (pH 7.5) 10 mM NaCI, 5 
mM MgCI,, 0.5% NP-40,0.2 mM PMBF to separate cytoplasmic from 
nuclear fractions by centrifugation. Nuclear fractions were subse- 
quently solubilized in lysis buffer containing 20 mM HEPES (pH 7.9). 
0.7 M NaCI, 10 mM EDTA, 1% NP-40.0.2 mM PMSF, 10 @ml aproti- 
nin (Sigma), leupeptin, and pepstatin A (Boehringer). Extracts were 
subsequently sonicated and resuspended in 2x Laemmli loading 
buffer (1 x final) and loaded directly. For the phosphorylation studies, 
1 mM orthovanadate and 50 mM NaF were also included. Western 
blot analysis of the extracts was performed as described elsewhere 
(antibodies, CSH). Specific antisera against RAG1 and RAG2 were 
incubated overnight, in 1 x 10 mM Tris (pH 8.0) 158 mM NaCI, 0.05% 
Tween (TBST), at 4OC and after three washings, antimouse or antirab 
bit IgM horseradish peroxidase (HRP)-conjugated antibodies (Amer- 
sham) were applied for 30 min at room temperature. Blots were washed 
three times and developed by enhanced chemiluminescence (ECL) 
(Amersham). 
Immunopreclpltetlon Assays 
Nuclear proteins were solubilized as described for Western blot, spe- 
cific monoclonal or polyclonal antisera were added, and reactions were 
incubated for 4 hr at 4OC. Subsequently, reactions were incubated 
with protein A/G-agarose beads (Oncogene Science) for 30 min at 
4OC, and after six washings in lysis buffer, beads were resuspended 
in Laemmli loading buffer (antibodies, CSH). lmmunoprecipitated 
products were separated on 8% polyacrylamide gels. The GST fusion 
proteins were collected on glutathione-agarose beads (Molecular 
Probes); after 1 hr incubation at 4OC. beads were washed three times 
and resuspended in Laemmli loading buffer. 
In Vlvo Protein Labetlng 
293T cells were transiently transfected with RAGl, RAGP, or both 
expressed in CDM8 and cells were subjected to labeling 48 hr after 
transfection. 3T3 cells were infected with the MFG retrovirus express- 
ing full-length RAGl, RAGP, or both as described (Pear et al., 1993; 
Silveret al., 1993). After 30 min of starvation in methionine-free DMEM, 
5% dialysed fetal calf serum (FCS) (GIBCO), cells were incubated with 
fresh DMEM medium containing 200 pCi/ml [=S]methionine (ICN) for 
3-4 hr. At the end of the labeling, medium was replaced with DMEM, 
10% FCS and cell lysates from different timepoints and equal number 
of cells were prepared as above. Primary thymocytes were treated 
similarly except they were grown in RPMI. (YP]orthophosphate label- 
ing was also performed in the presence of dialysed FCS in DMEM- 
or RPMI-free of sodium pyruvate (GIBCO). Cells were also labeled for 
3 hr but cell lysates were prepared in the presence of 50 pg/ml DNasel 
and 108 @ml RNaseA. lmmunoprecipitations were performed as de- 
scribed above. Radioactivity was quantitated by Phosphoimager (Mo- 
lecular Dynamics) analysis as well as image scanning of autoradio- 
grams (National Institutes of Health, Image Program 1.52). 
tmmunofluorescence 
Mouse primary thymocytes from postnatal day 7 were teased out of 
the thymus, immobilized on glass slides by cytospin, fixed in 50% 
methanol, 50% acetone, rehydrated in phosphate-buffered saline, pre- 
blocked with TBST, 2% donkey serum, 2% bovine serum albumin for 
1 hr (1 x TBST = 10 mM Tris [pH 8.0],150 mM NaCI. 0.05% Tween), 
incubated with the primary antibody (for RAGI, mouse MAbl, for 
RAG2 affinity-purified rabbit polyclonal, pAb2) in TBST, 1% donkey 
serum, 1% bovine serum albumin for 2 hr at room temperature. Slides 
were then washed three times in TBST, preblocked for 10 min, and 
incubated with rhodaminated donkey anti-mouse or anti-rabbit F(ab)n 
(Jackson Immunoresearch) for 30 min. After three washes with TBST, 
samples were air dried very briefly before mounting with fluorescent 
G and coverslip protection. Cells were visualized with Nikon fluores- 
cence. 3T3 fibroblasts stably expressing full-length RAG1 or RAG2 
were infected by pGD retroviral-RAG DNA as described (Pear et al., 
1993). The GST fusion proteins were expressed in 293T cells. 293T 
cells growing in DMEM, 10% FCS were transfected by calcium phos- 
phate precipitation in 35 mm tissue culture plastic dishes. The medium 
was removed 48 hr later and cells were washed gently, twice with 
phosphate-buffered saline. Subsequently, the cells were fixed on the 
plastic by 50% methanol, 50% acetone treatment for 3 min. Cells 
were then rehydrated in phosphate-buffered saline and treated and 
visualized similarly to the thymocyte preparations (see above). 
Yeast Two-Hybrid Screening 
Screening was performed as described (Zervos et al., 1993; Codes 
et al., 1994). 
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